These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3716373)

  • 21. Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall.
    Satoskar AA; Molenda M; Scipio P; Shim R; Zirwas M; Variath RS; Brodsky SV; Nadasdy GM; Hebert L; Rovin B; Nadasdy T
    Clin Nephrol; 2013 Apr; 79(4):302-12. PubMed ID: 23320971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
    Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
    Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Henoch-Schönlein purpura.
    Reamy BV; Williams PM; Lindsay TJ
    Am Fam Physician; 2009 Oct; 80(7):697-704. PubMed ID: 19817340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of oligo-anuric forms of acute glomerulonephritis].
    Zosin C; Mănescu N
    Med Interna (Bucur); 1973 Jun; 25(6):667-76. PubMed ID: 4793938
    [No Abstract]   [Full Text] [Related]  

  • 28. Henoch-Schönlein purpura.
    Saulsbury FT
    Curr Opin Rheumatol; 2010 Sep; 22(5):598-602. PubMed ID: 20473173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of early corticosteroid therapy on development of Henoch-Schönlein nephritis.
    Bayrakci US; Topaloglu R; Soylemezoglu O; Kalyoncu M; Ozen S; Besbas N; Bakkaloglu A
    J Nephrol; 2007; 20(4):406-9. PubMed ID: 17879205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.
    Bergstein J; Leiser J; Andreoli SP
    Clin Nephrol; 1998 Jan; 49(1):9-14. PubMed ID: 9491279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome in children after Henoch-Schonlein purpura nephritis.
    Butani L; Morgenstern BZ
    Clin Pediatr (Phila); 2007 Jul; 46(6):505-11. PubMed ID: 17579102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Henoch-Schönlein Purpura: A Literature Review.
    Hetland LE; Susrud KS; Lindahl KH; Bygum A
    Acta Derm Venereol; 2017 Nov; 97(10):1160-1166. PubMed ID: 28654132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Favorable effects of epsilon-aminocaproic acid on the children with nephrotic syndrome and Schonlein-Henoch syndrome treated with corticosteroids].
    Prandota J; Panków-Prandota L; Rotter A; Kotecki L
    Pol Merkur Lekarski; 1996 Oct; 1(4):241-5. PubMed ID: 9156934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.
    Donnithorne KJ; Atkinson TP; Hinze CH; Nogueira JB; Saeed SA; Askenazi DJ; Beukelman T; Cron RQ
    J Pediatr; 2009 Jul; 155(1):136-9. PubMed ID: 19559299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Henoch Schonlein purpura.
    Tizard EJ; Hamilton-Ayres MJ
    Arch Dis Child Educ Pract Ed; 2008 Feb; 93(1):1-8. PubMed ID: 18208978
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple and recurrent intestinal perforations: an unusual complication of Henoch-Schonlein purpura.
    Yigiter M; Bosnali O; Sekmenli T; Oral A; Salman AB
    Eur J Pediatr Surg; 2005 Apr; 15(2):125-7. PubMed ID: 15877262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
    Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
    Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinico-morphological features and the course of glomerulonephritis in hemorrhagic vasculitis].
    Nikolaev AIu; Tareeva IE; Pal'tsev MA; Shcherbin AA; Varshavskiĭ VA
    Ter Arkh; 1987; 59(8):44-8. PubMed ID: 3686445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schönlein-Henoch's syndrome in children.
    Kobayashi O; Wada H; Okawa K; Takeyama I
    Contrib Nephrol; 1975; 4():48-71. PubMed ID: 1235099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.